ACE2 and COVID-19: Sera obtained from vaccinated individuals, hybrid sera and negative controls (pre-COVID-19 and pre-vaccinated sera), were tested with sVNA for their antibodies’ ability to neutralize the trimeric S(6P)-StrepTag-ACE2 interaction, and the results produced were correlated with those of the RBD-sVNT cPass inhibition assay.